The epidemiological backbone of the review comes from large longitudinal cohorts. In a meta-analysis pooling more than 474,000 participants across eight countries with follow-up periods of 7 to 25 years, Cappuccio and colleagues found that habitual sleep of less than six hours per night was associated with a 48 percent higher risk of developing or dying from coronary heart disease and a 15 percent increase in the risk of fatal or nonfatal stroke. Other analyses reported that people sleeping under six hours were roughly twice as likely to experience myocardial infarction or stroke as those sleeping seven to eight hours, an effect most pronounced in middle-aged adults, precisely the stage of life when work and family demands most often erode sleep. The relationship follows a U-shaped curve: both short and unusually long sleep durations outside the six-to-nine-hour range carry elevated cardiovascular risk, complicating any simple prescription to simply sleep more.

Blood pressure provides one of the clearest mechanistic windows. In a cohort of 4,810 adults followed for a decade, those habitually sleeping five hours or less had an adjusted hazard ratio of 2.10 for developing hypertension, and the Sleep Heart Health Study, spanning nearly 6,000 men and women, found adjusted odds ratios of 1.66 for people sleeping under six hours compared with seven to eight. The physiological consequences of even acute restriction are measurable in young, healthy volunteers: a single night of sleep deprivation raised 24-hour systolic blood pressure by 5.2 mmHg and heart rate by 3.8 beats per minute, while total sleep deprivation produced persistent tachycardia in response to acute stress. Over twenty years, researchers tracking 495 healthy adults found that each hour of reduced sleep was associated with a 33 percent higher risk of coronary artery calcification, a direct structural footprint of chronic sleep debt inside the vessel wall.

The review details the neuroendocrine machinery behind these numbers. Sleep restriction activates the sympathetic nervous system, sustaining a pre-hypertensive, pro-atherogenic state of vasoconstriction, endothelial dysfunction, and impaired vascular repair. Simultaneously, the hypothalamic-pituitary-adrenal axis is perturbed: after just two nights of four-hour sleep, healthy young men showed ACTH and cortisol levels elevated by 19 and 21 percent respectively, and sleep-restricted women lost the normal daytime decline in cortisol, prolonging exposure to a hormone that drives vasoconstriction and hypertension. Sleep loss also suppresses growth hormone, which is secreted predominantly during deep N3 slow-wave sleep and is essential for maintaining the arterial endothelium and myocardial mass; growth hormone deficiency is linked to accelerated atherosclerosis and heightened heart failure risk. During intact N3 sleep, parasympathetic tone rises and blood pressure and heart rate fall, making deep sleep a nightly window of cardiovascular recovery that curtailed sleep systematically erodes.

Perhaps the most vivid natural experiment cited is the annual daylight saving time transition, which acutely deprives more than 1.5 billion people of roughly one hour of sleep. Analyzing hospital records, Sadhu and colleagues found a 24 percent increase in myocardial infarctions the day after the spring clock change, and a 21 percent decrease the day after the fall change when people gain an hour. Yet the authors urge caution: the effects are transient, derived from observational data, and recent large-scale studies in Ireland and the United States found no significant difference in heart attack incidence during transition weeks. The divergence illustrates a broader theme of the review, that circadian effects on cardiovascular outcomes are real in controlled settings but often modest, context-dependent, and easily obscured by comorbidities, activity patterns, and healthcare system factors in the messy real world.

On the metabolic side, the evidence is equally convergent. In a landmark experiment by Van Cauter’s group, eleven healthy young men restricted to four hours of sleep for six nights showed a 40 percent drop in glucose clearance and a 30 percent lower insulin response, a profile the authors described as comparable to a prediabetic state, which partially reversed after recovery sleep. A six-week study in 38 women found increased insulin resistance during short sleep independent of adiposity, and population studies across cultures consistently tie habitual short sleep to type 2 diabetes, with short sleepers showing higher HbA1c levels. The economic stakes are enormous: the American Diabetes Association estimated diabetes-related health costs at 300 billion dollars annually, with obesity-associated costs reaching two trillion.

Appetite regulation offers a second metabolic pathway. Sleep loss raises ghrelin, the stomach-derived hunger signal, and lowers leptin, the adipose-derived satiety signal; short sleepers showed ghrelin levels 14 percent higher than normal sleepers. Sleep restriction also elevates endocannabinoids such as 2-arachidonoylglycerol, which decline more slowly in the evening and sustain cravings for palatable food, a hormonal profile functionally reminiscent of cannabis-induced munchies. The behavioral consequences are quantifiable: a meta-analysis of 17 trials found partial sleep deprivation increased daily intake by roughly 253 calories, with cravings for salty, sugary, and starchy foods rising 30 to 40 percent while protein, fruit, and vegetable intake rose only modestly. Neuroimaging explains the shift: after total sleep deprivation, the amygdala over-responds to images of energy-dense food while prefrontal executive control weakens, and participants desired roughly 600 additional calories. Crucially, energy expenditure barely changes, rising by only about 134 kilocalories even under total sleep deprivation, so the extra intake lands as a net surplus, producing measurable weight gain and visceral fat accumulation in controlled trials.

The review extends the picture to the gut microbiome and circadian misalignment. Sleep disruption shifts the balance of intestinal bacteria, decreasing Bacteroidetes and increasing Firmicutes, a ratio associated with obesity and insulin resistance, while elevated cortisol promotes pathogenic bacterial growth. Shift workers show elevated tumor necrosis factor alpha and interleukin 6 alongside reduced adiponectin, an anti-inflammatory, insulin-sensitizing protein, providing an inflammatory route from circadian disruption to metabolic syndrome. Social jet lag, the mismatch between biological chronotype and socially imposed sleep timing, tracks with body mass index, waist circumference, C-reactive protein, and HbA1c in community cohorts, and even in adolescents, greater social jet lag and morning circadian misalignment correlate with reduced insulin sensitivity. In children, short sleep is associated with a 35 to 41 percent higher likelihood of obesity, and sleep restriction during dieting redirects weight loss away from fat and toward lean tissue, undermining the metabolic benefits of caloric restriction.

Encouragingly, the review highlights early interventional evidence that the damage is partly reversible. Extending sleep from 6.5 to 8.5 hours per night for two weeks reduced appetite by 14 percent and cravings for unhealthy snacks by 65 percent in overweight adults. A four-week sleep extension trial cut daily sugar intake by 9.6 grams, another study improved blood pressure with a 35-minute nightly sleep increase, and six weeks of one extra hour of sleep significantly improved insulin sensitivity in habitually short sleepers. The authors caution that much of the literature remains observational, that mechanistic studies have skewed toward male participants, and that causal inference is limited by possible reverse causality. They call for longitudinal designs combining sleep phenotyping with multi-omics profiling, and for trials testing whether sleep extension, cognitive behavioral therapy for insomnia, or treatment of sleep-disordered breathing can restore hormonal homeostasis. As modern life continues to compress sleep, the message is that a good night’s rest is not a luxury but a measurable pillar of cardiovascular and metabolic prevention.

Subject of Research: The effects of sleep deprivation and circadian misalignment on cardiovascular and metabolic disease risk

Article Title: Sleep loss as a cardiometabolic risk factor: a narrative review of clinical and public health implications

Article References: Ghanem, F. K., Attarian, H., Al-Khalil, Z., & Kabrita, C. S. (2026). Sleep loss as a cardiometabolic risk factor: a narrative review of clinical and public health implications. Journal of Clinical Sleep Medicine, 22(1), Article 129. https://doi.org/10.1007/s44470-026-00144-1

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00144-1

Keywords: sleep deprivation, cardiometabolic disease, circadian misalignment, hypertension, insulin resistance, obesity, leptin, ghrelin, endocannabinoids, metabolic syndrome, slow-wave sleep, daylight saving time